5月27日，波士顿科学盘中下跌8.13%，报51.97美元/股，成交额3.52亿美元。
消息面上，高盛将波士顿科学目标价从84美元下调至81美元，维持买入评级，据FactSet统计，该股当前分析师平均目标价为83.63美元。此外，FDA近期披露波士顿科学将对部分起搏器进行软件升级召回，对市场情绪形成压制。基本面方面，公司一季度营收52.03亿美元，同比增长11.58%，归母净利润13.41亿美元，同比增长98.96%，业绩表现稳健但未能抵消多重利空冲击。当前股价距52周高点109.50美元已回落逾52%。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.